Carcinoid tumor and intravenous octreotide infusion during labor and delivery

Int J Obstet Anesth. 2009 Apr;18(2):182-5. doi: 10.1016/j.ijoa.2008.10.005. Epub 2009 Feb 5.

Abstract

There are limited numbers of reports concerning the management of pregnancy complicated by carcinoid tumors. Octreotide, the synthetic analogue of somatostatin, has been found to be beneficial in preventing the perioperative exacerbation of carcinoid syndrome. We present a case of the successful use of neuraxial analgesia/anesthesia for labor and vaginal delivery in a symptomatic parturient afflicted with carcinoid syndrome, who received an intravenous infusion of octreotide throughout labor and vaginal delivery.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anesthesia, Obstetrical*
  • Anesthesia, Spinal*
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Carcinoid Tumor / complications*
  • Carcinoid Tumor / drug therapy*
  • Delivery, Obstetric
  • Female
  • Humans
  • Infant, Newborn
  • Infusions, Intravenous
  • Octreotide / administration & dosage
  • Octreotide / therapeutic use*
  • Pregnancy
  • Pregnancy Complications, Neoplastic / drug therapy*

Substances

  • Antineoplastic Agents, Hormonal
  • Octreotide